FASEB J. </> Kunkel Society in Santa Marghertia
</cgi/adclick/?ad=16635&adclick=true&url=http%3A%2F%2Fwww.henrykunkelsociety.org%2Fmeetings.asp>

HOME </> 	HELP </help/> 	FEEDBACK </cgi/feedback> 	SUBSCRIPTIONS
</subscriptions> 	ARCHIVE </contents-by-date.0.shtml> 	SEARCH
</search.dtl> 	

		

	*/QUICK/ SEARCH: * 	 [advanced] </search.dtl> 	
	
	Author:
	Keyword(s):
Year:  		Vol:  		Page:  	

	


------------------------------------------------------------------------

------------------------------------------------------------------------

*Editorial Policies*

/FJ Express/ Citations <#citation>
Errata <#errata>
Misconduct Policy <#misconduct>
Embargo Policy <#embargo>
Press Access <#press>
Peer Review Process Including Rebuttal Policy <#peer>
Conflict of Interest Disclosure <#conflict>
Criteria for Authorship <#authorship>
Procedures for Changes in Authorship after Acceptance <#changes>
Statement on the Ethical Use of Humans and/or Animals in Research <#ethics>
Access to Unique Materials such as Cell Lines, Organisms, and Software
<#unique>
Copyright and Permissions Policy <#copyright>
The NIH Public Access Policy and Your Manuscript <#nih>


*/FJ Express/ Citations*
There have been a number of issues raised by authors regarding how
citations to the /The FASEB Journal/ are handled by Thomson ISI. As a
result there has been an ongoing dialog between FASEB staff and Thomson
ISI regarding these issues. Please see the letter from Thomson ISI
<Thomson-ISI-letter.shtml> for more information.

*Errata*
/The FASEB Journal/ makes every effort to publish error-free
manuscripts, providing authors with page proofs before publication.
There are occasions, however, when it is necessary to publish a
correction. Errata may be sent directly to journals@faseb.org
<mailto:journals@faseb.org>.

The author will be assessed page charge(s) for errata that result from
author error. The journal will cover the costs of errata that are a
result of the editing process.

*Misconduct*
/The FASEB Journal/ only accepts research papers that are original
works, no part of which has been submitted for publication elsewhere
except as brief abstracts. Duplicate publication, falsification,
plagiarism, or fabrication will be considered actionable misconduct.
Misconduct does not include honest error or honest differences in
interpretations or judgments of data.

If there is a suspicion or allegation of misconduct directed toward any
author, /The FASEB Journal/ reserves the right to forward relevant
material to the appropriate authorities at the author's institution for
investigation. /The FASEB Journal/ recognizes its responsibility to
ensure that the suspicion of misconduct has been addressed, but the
journal does not make such determinations.

The Editor-in-Chief is responsible for the specific editorial conduct of
/The FASEB Journa/l and compliance with the relevant policies and
procedures. When a report of suspected misconduct has been sent to the
Editor-in-Chief, the following course of action will be taken. If the
manuscript has yet to be published, all work on the manuscript will
stop. No immediate action to already-published material (such as
retracting an online pre-print article) will be taken until the matter
is resolved. In cases of minor issues, the Editor-in-Chief will contact
the corresponding author directly. In cases of major issues, the
Editor-in-Chief will inform the Publications Communications Committee
(PCC) Chair of the accusation through the Director of Publication by
supplying copies of 1) the relevant material and 2) a draft letter to
the corresponding author asking for an explanation in a nonjudgmental
manner. In some cases, the Editor-in-Chief may contact all of the
authors listed on the manuscript. Should the corresponding author?s
response fail to resolve the situation satisfactorily, the
Editor-in-Chief will contact all of the institutions of the contributing
authors. The institutions should then make an inquiry and report back to
the Editor-in-Chief. Until the matter is clarified, no papers by any
authors on the disputed manuscript will be considered for publication.

If scientific misconduct is confirmed by institutional review, the
Editor-in-Chief will report this to the PCC Chair and the FASEB
Executive Director. Appropriate action will be decided in consultation
with the FASEB Office of Publications. Violations considered severe may
warrant official withdrawal of a published article or rapid rejection of
a manuscript at any stage before publication. If the infraction is less
severe, the Editor-in-Chief will send the corresponding author a letter
of reprimand reviewed by the PCC Chair. If FASEB has violated the
copyright of another journal, the PCC Chair will write a letter of
apology to the other journal?s Editor-in-Chief. If no scientific
misconduct is found, the manuscript (if unpublished) will be scheduled
for publication. For errors in a published article not deemed to be
misconduct, an Erratum or Letter to the Editor will be published. If
there is a disagreement about the results of the investigation, the
Editor-in-Chief reserves the right to restrict the author(s) from
publishing in the journal for a specified period of time.

*Embargo Policy*
Authors or their representatives (hereafter called authors) may mention
to the press the title of the article, authors and their affiliations,
date of publication, and citation information before publication/posting.

We ask that authors refrain from publishing large quotes, substantial
analysis, or reprinting figures, tables, or other data until the
publication/posting date. Authors are welcome to present more detailed
information at professional conferences, but authors should refrain from
giving out overheads or other handouts that contain substantial material
from your article before your publication/posting date.

For the embargo date and time for a specific article, please contact
journals@faseb.org <mailto:journals@faseb.org> or phone (301) 634-7104.

*Press Access*
Members of the press, public affairs officers, and other science writers
may request pre-publication copies of articles. For further details,
please contact journals@faseb.org <mailto:journals@faseb.org> or phone
(301) 634-7104.

Credentialed members of the press may request free online access to the
journal. For further details, please contact journals@faseb.org
<mailto:journals@faseb.org> or phone (301) 634-7104.

*Peer Review Process Including Rebuttal Policy*
Before an article is submitted to the journal, authors must submit an
initial query (IQ). From this, the Editor-in-Chief and Associate Editors
determine if the subject matter is suitable for consideration. An IQ may
be sent to an Editorial Board Member for further consideration before a
determination is made.

Manuscripts requested after the IQ stage are reviewed critically. After
receipt of a manuscript by the Editor-in-Chief, it is sent to an
Associate Editor who sends the manuscript to an appropriate number of
reviewers (usually two, depending on the type of manuscript). Editors
may ask for suggested reviewer names from an Editorial Board Member.
Comments from reviewers are examined by the Editor-in-Chief and/or
Associate Editors, who make the final decisions. Rebuttals should be
addressed to the Editor-in-Chief at journals@faseb.org
<mailto:journals@faseb.org>.

All reviewers remain unknown to the authors. Every manuscript is treated
by the Editors and reviewers as privileged information, and they are
instructed to exclude themselves from review of any manuscript that
might involve a conflict of interest or the appearance thereof.

Upon submission of a manuscript, authors must suggest five potential
reviewers who have not seen the manuscript before submission. Authors
may request disqualification of up to four potential reviewers. Only
those individuals who would represent a direct conflict of interest
should be excluded. Authors cannot make an extensive or blanket
disqualification of a group of possible reviewers, e.g., all potential
competitors in one or more industrial laboratories or academic
departments. Requests to disqualify reviewers will be honored at the
discretion of the Editor assigned to the manuscript.

*Conflict of Interest Disclosure*
Authors of research articles are required at the time of submission to
disclose any potential conflict of interest (e.g., consultancies, stock
ownership, equity interests, patent-licensing arrangements) and that
they accept full responsibility for the conduct of the study, had full
access to all the data, and controlled the decision to publish. Failure
to do so may jeopardize eventual publication. Such potential conflict,
unless already disclosed in the submitted article, will be held in
confidence while the paper is under review. If the article is accepted
for publication, information on the potential conflict of interest will
be included in the acknowledgments section of the article.

Send disclosures to journals@faseb.org <mailto:journals@faseb.org>.
Please make sure the disclosure includes the number of your manuscript.

*Criteria for Authorship*
The Editors expect each author to have made an important scientific
contribution to the study and be thoroughly familiar with the original
data. The Editors also expect each author to have read the complete
manuscript and to take responsibility for the content and completeness
of the manuscript and to understand that if the paper, or part of the
paper, is found to be faulty or fraudulent, that he/she shares
responsibility with his/her coauthors. Because we hold each author to
this high standard, the copyright form must be signed by every author.
Furthermore, if a manuscript has 10 or more authors, each author will be
required to submit a statement of authorship to the Journal stating that
he or she has read each page of the paper and consents to the paper
being submitted to the Journal for publication.

*Procedures for Changes in Authorship after Acceptance*
All substantial changes in authorship (additions, removals, or change of
order) requested after acceptance must be approved by the
Editor-in-Chief. Changes must be requested by the corresponding author
and sent to journals@faseb.org <mailto:journals@faseb.org>. The
Editor-in-Chief reserves the right to accept the request, reject the
request, withdraw the manuscript from consideration/publication, or
retract a published article based on the nature and extent of the
circumstances related to the request. All decisions by the
Editor-in-Chief in these matters are final.

*Statement on the Ethical Use of Humans and/or Animals in Research*
The research described in submitted manuscripts that involves the use of
human beings, including healthy volunteers, must adhere to the
principles of the Declaration of Helsinki as well as to Title 45, U.S.
Code of Federal Regulations, Part 46, Protection of Human Subjects,
Revised November 13, 2001, effective December 13, 2001. Research
involving animals must adhere Public Health Service Policy on Humane
Care and Use of Laboratory Animals. All investigations involving humans
or animals reported in its publications must be conducted in conformity
with these principles. In addition, all investigations involving humans
or animals must be approved by an appropriate institutional review
committee.

*Access to Unique Materials such as Cell Lines, Organisms, and Software*
Authors of papers published in the Journal are obligated to honor any
reasonable request by qualified investigators for unique propagative
materials, such as cell lines, hybridomas, DNA clones, and organisms
that are described in the paper. If computer software programs are
developed and used in submitted manuscripts, the programs must be made
available to the reviewer upon request. The source code or the program
must be made available, either commercially or in downloadable form from
the authors, if the manuscript is accepted for publication. The Journal
reserves the right to deny further publication rights to authors
unwilling to abide by these principles.

/The FASEB Journal/ also does not distinguish between microarray data
and other sorts of data (proteomics, sequence data, organic syntheses,
crystal structures, etc.) All methods must be publicly available and
described. Anything published in / The FASEB Journal/ must have all data
available not only for review but to every reader, electronic or print.

*Copyright and Permissions Policy*
Copyright of published manuscripts is held by the Federation of American
Societies for Experimental Biology (FASEB), which must receive the
assignment of copyright from the authors of accepted manuscripts. FASEB
holds copyright for the protection of authors and FASEB. Authors seeking
permission to republish portions of their own work published in the
Journal, authors seeking to republish material in publications owned by
not-for-profit organizations, and students wanting to include material
in dissertations, theses, etc., should submit a permission request to
the editorial office. All other permission requests are handled through:

Copyright Clearance Center, Inc.
222 Rosewood Dr.
Danvers, MA 01923
Copyright.com <http://www.copyright.com>

The CCC also handles permissions to make copies of articles. Although
authors are always granted rights to reproduce figures or tables from
their own works free of charge, we ask that formal permission be applied
for via the form located here </misc/copyright.shtml>.

Upon publication of their manuscript, authors may request a pdf file of
their article. Authors may not post this article to the Internet.
However, authors may link to their article on /The FASEB Journal's/ Web
site.

The Journal grants the Author permission to provide a copy of the
accepted manuscript to NIH upon acceptance for Journal publication, with
public release in PubMed Central twelve months after final print
publication by the Journal.

*NIH Public Access Policy*
Under the NIH Public Access Policy, NIH is asking its funded
investigators to voluntarily submit to PubMed Central (PMC) the author?s
final manuscript of articles resulting from research supported in whole
or in part with direct costs from NIH. According to the NIH, this policy
applies only to manuscripts accepted for publication on or after May 2,
2005.

If you choose to submit your accepted manuscript to PMC, you will be
asked to indicate when that manuscript should be made available to the
public. As copyright holder of your article, the Federation of American
Societies for Experimental Biology (FASEB) has the sole right to publish
or disseminate it. FASEB, however, grants authors one-time permission to
allow public release of their manuscript through PMC 12 months after
publication in /The FASEB Journal/.

This period of time is consistent with our existing policy to make all
content publicly available through HighWire Press 12 months after print
publication. NIH will be able to determine when 12 months have elapsed
because FASEB sends NIH electronic feeds of the article metadata upon
publication in the journal. You can, therefore, submit your accepted
manuscript to PMC at the time of acceptance and will not have to
calculate or track time elapsed from publication. Participation in the
NIH policy is voluntary and, according to NIH officials, there will be
no sanctions of any kind against authors who do not submit their
manuscripts. If you have any questions with respect to the NIH Public
Access Policy and the publication of your article in /The FASEB
Journal/, please contact Jennifer Pesanelli at jpesanelli@faseb.org
<mailto:jpesanelli@faseb.org>.

------------------------------------------------------------------------
HOME </> 	HELP </help/> 	FEEDBACK </cgi/feedback> 	SUBSCRIPTIONS
</subscriptions> 	ARCHIVE </contents-by-date.0.shtml> 	SEARCH
</search.dtl> 	

*Copyright © 2008 by The Federation of American Societies for
Experimental Biology. </misc/terms.shtml>*
